Larvol Delta - OSU16077-Ibrutinib-and-Nivolumab-in-Treating-Patients-With-Relapsed-or-Refractory-Classical-Hodgkin-Lymphoma

Imbruvica (ibrutinib) - AbbVie, J&J

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://clinicaltrials.gov/ct2/show/NCT02940301

Sep 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next